Rna Diagnostics Announces $5M Series A Financing Round Led by iGAN Partners
Rna Diagnostics Inc., a Canadian company with a patented platform technology providing real-time cancer therapy guidance, announced today the closing of a $5 million Series A financing. The funding was led by iGAN Partners and includes new and existing investors. Rna Diagnostics' platform technology is the RNA Disruption Assay™ (RDA). RDA is a diagnostic test that